BioNTech SE 4

BioNTech SE COO Sierk Poetting, via Tofino GmbH, sold 50,000 ordinary shares for about $5.5 million and now indirectly owns 399,387 shares.

On April 22, 2026, BioNTech SE Chief Operating Officer Sierk Poetting, through his beneficial ownership of Tofino GmbH, sold 50,000 ordinary shares at an average price of approximately $110.56 per share, for total proceeds of about $5.53 million. Following this disposition, Poetting’s indirect ownership stood at 399,387 ordinary shares held via Tofino GmbH, as disclosed in the filing footnote. The transaction represents a sizable insider sale but appears to be a single, straightforward open-market disposition rather than part of a compensatory award or option exercise.

Filing Facts

CIK

1776985

Ticker

BNTX

Form

4

Source Type

sec

Accession

0001955589-26-000002

Alert Tier

7